FPH.AX Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 09:10):

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide...

Stats
Šios dienos apimtis	192 911
Vidutinė apimtis	303 535
Rinkos kapitalizacija	15.07B
EPS	$0.125 ( 2020-09-29 )
Kita pelno data	( $0 ) 2024-05-28
Last Dividend	$0.212 ( 2023-06-26 )
Next Dividend	$0 ( N/A )
P/E	62.93
ATR14	$0.0120 (0.05%)

Tūris Koreliacija

Ilgas: 0.19 (neutral)

Trumpas: -0.43 (neutral)

Signal:(60.219) Neutral

Fisher & Paykel Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Fisher & Paykel Koreliacija - Valiuta/Žaliavos

0.18
( neutral )

0.28
( neutral )

0.00
( neutral )

-0.52
( weak negative )

0.58
( weak )

Fisher & Paykel Finansinės ataskaitos

Annual	2023
Pajamos:	$1.49B
Bruto pelnas:	$885.34M (59.54 %)
EPS:	$0.410

FY	2023
Pajamos:	$1.49B
Bruto pelnas:	$885.34M (59.54 %)
EPS:	$0.410

FY	2022
Pajamos:	$1.52B
Bruto pelnas:	$938.68M (61.70 %)
EPS:	$0.610

FY	2021
Pajamos:	$1.95B
Bruto pelnas:	$1.22B (62.76 %)
EPS:	$0.915

Financial Reports:

No articles found.

Fisher & Paykel Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0.165 (N/A)	$0 (N/A)	$0.212 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Fisher & Paykel Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.72 - Stable (34.44%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0500	2002-06-07
Last Dividend	$0.212	2023-06-26
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	42	--
Total Paid Out	$3.24	--
Avg. Dividend % Per Year	0.00%	--
Score	4.12	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.72
Div. Directional Score	9.00	--

Next Divdend (Est)
(2024-10-21)

$0.221 Estimate 3.71 %

Dividend Stability

0.30 Very Poor

Dividend Score

4.12

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
FID.AX	Ex Dividend Knight	2023-08-25	Semi-Annually	0.00%
PRU.AX	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
ASG.AX	Ex Dividend Junior	2023-10-31	Annually	0.00%
IFT.AX	Ex Dividend Knight	2023-05-29	Semi-Annually	0.00%
SFC.AX	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
CD1.AX	Ex Dividend Junior	2023-08-17	Semi-Annually	0.00%
MEZ.AX	Ex Dividend Knight	2023-09-06	Semi-Annually	0.00%
TOP.AX	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
CWP.AX	Ex Dividend Junior	2023-09-27	Semi-Annually	0.00%
NSR.AX	Ex Dividend Knight	2023-06-29	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.153	1.500	6.94	10.00	[0 - 0.5]
returnOnAssetsTTM	0.110	1.200	6.34	7.61	[0 - 0.3]
returnOnEquityTTM	0.144	1.500	9.51	10.00	[0.1 - 1]
payoutRatioTTM	0.563	-1.000	4.37	-4.37	[0 - 1]
currentRatioTTM	2.54	0.800	2.29	1.830	[1 - 3]
quickRatioTTM	1.059	0.800	8.48	6.78	[0.8 - 2.5]
cashRatioTTM	0.246	1.500	9.75	10.00	[0.2 - 2]
debtRatioTTM	0.128	-1.500	7.87	-10.00	[0 - 0.6]
interestCoverageTTM	26.34	1.000	1.354	1.354	[3 - 30]
operatingCashFlowPerShareTTM	0.632	2.00	9.79	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0505	2.00	9.97	10.00	[0 - 20]
debtEquityRatioTTM	0.174	-1.500	9.30	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.601	1.000	3.32	3.32	[0.2 - 0.8]
operatingProfitMarginTTM	0.219	1.000	7.63	7.63	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.288	1.000	3.95	3.95	[0.2 - 2]
assetTurnoverTTM	0.717	0.800	8.56	6.84	[0.5 - 2]
Total Score				11.27

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	61.27	1.000	3.91	0	[1 - 100]
returnOnEquityTTM	0.144	2.50	9.68	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0505	2.00	9.98	10.00	[0 - 30]
dividendYielPercentageTTM	1.294	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.632	2.00	9.79	10.00	[0 - 30]
payoutRatioTTM	0.563	1.500	4.37	-4.37	[0 - 1]
pegRatioTTM	0.817	1.500	7.89	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.230	1.000	6.75	0	[0.1 - 0.5]
Total Score				6.72

Fisher & Paykel

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.